There are currently no FDA-approved treatments for CTD. In winning the competition, Player 831 hopes to fund critical research, drug development, clinical trials, and resources for families ...
Bioheng Therapeutics US LLC has obtained IND approval from the FDA for CTD-402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with relapsed or ...
CTD is a rare genetic disorder that limits the ... in high-impact translational projects including gene therapy and drug repurposing, with multiple ongoing projects showing promising results.
CTD is a rare genetic disorder that limits the brain’s ability to access creatine—an essential compound for energy and development. This condition impacts speech, cognitive abilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results